Income Statement DermTech
Stocks
DMTK
US24984K1051
Investment Holding Companies
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 25-08-12 | DermTech, Inc. Went Out of Business | CI |
| 25-05-22 | Fourth Motion for Exclusivity Period Extension Approved For DermTech, Inc. | CI |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
Revenues | 3.36M | 5.88M | 11.84M | 14.52M | 15.3M | ||
Total Revenues | 3.36M | 5.88M | 11.84M | 14.52M | 15.3M | ||
Cost of Goods Sold, Total | 3.3M | 5.98M | 10.56M | 13.87M | 15.02M | ||
Gross Profit | 60K | -96K | 1.27M | 647K | 276K | ||
Selling General & Admin Expenses, Total | 15.17M | 28.89M | 62.41M | 94.76M | 83.08M | ||
R&D Expenses | 2.5M | 5.29M | 16.26M | 24.05M | 15.24M | ||
Other Operating Expenses, Total | 17.66M | 34.18M | 78.67M | 119M | 98.32M | ||
Operating Income | -17.6M | -34.28M | -77.4M | -118M | -98.04M | ||
Interest Expense, Total | -2.66M | - | -17K | -13K | -5K | ||
Interest And Investment Income | - | 40K | 168K | 1.35M | 2.85M | ||
Net Interest Expenses | -2.66M | 40K | 151K | 1.34M | 2.85M | ||
Other Non Operating Income (Expenses) | -355K | - | -1.09M | 141K | 5K | ||
EBT, Excl. Unusual Items | -20.62M | -34.24M | -78.34M | -117M | -95.19M | ||
Restructuring Charges | - | - | - | - | -2.1M | ||
Legal Settlements | - | -1.01M | - | - | - | ||
Other Unusual Items | 928K | - | - | - | -3.6M | ||
EBT, Incl. Unusual Items | -19.69M | -35.25M | -78.34M | -117M | -101M | ||
Earnings From Continuing Operations | -19.69M | -35.25M | -78.34M | -117M | -101M | ||
Net Income to Company | -19.69M | -35.25M | -78.34M | -117M | -101M | ||
Net Income - (IS) | -19.69M | -35.25M | -78.34M | -117M | -101M | ||
Net Income to Common Incl Extra Items | -19.69M | -35.25M | -78.34M | -117M | -101M | ||
Net Income to Common Excl. Extra Items | -19.69M | -35.25M | -78.34M | -117M | -101M | ||
Per Share Items | |||||||
Net EPS - Basic | -2.81 | -2.08 | -2.71 | -3.88 | -3.09 | ||
Basic EPS - Continuing Operations | -2.81 | -2.08 | -2.71 | -3.88 | -3.09 | ||
Basic Weighted Average Shares Outstanding | 7.01M | 16.98M | 28.88M | 30.04M | 32.64M | ||
Net EPS - Diluted | -2.81 | -2.08 | -2.71 | -3.88 | -3.09 | ||
Diluted EPS - Continuing Operations | -2.81 | -2.08 | -2.71 | -3.88 | -3.09 | ||
Diluted Weighted Average Shares Outstanding | 7.01M | 16.98M | 28.88M | 30.04M | 32.64M | ||
Normalized Basic EPS | -1.84 | -1.26 | -1.69 | -2.43 | -1.82 | ||
Normalized Diluted EPS | -1.84 | -1.26 | -1.69 | -2.43 | -1.82 | ||
Supplemental Items | |||||||
EBITDA | -17.52M | -33.79M | -76.4M | -117M | -96.22M | ||
EBITA | -17.6M | -34.28M | -77.4M | -118M | -98.04M | ||
EBIT | -17.6M | -34.28M | -77.4M | -118M | -98.04M | ||
EBITDAR | -16.82M | -31.99M | -74.23M | -111M | -86.68M | ||
Total Revenues (As Reported) | 3.36M | 5.88M | 11.84M | 14.52M | 15.3M | ||
Normalized Net Income | -12.89M | -21.4M | -48.96M | -72.93M | -59.49M | ||
Interest on Long-Term Debt | 11K | 3K | 17K | 13K | 5K | ||
Supplemental Operating Expense Items | |||||||
Selling and Marketing Expenses | 6.3M | 16.08M | 37.58M | 58.67M | 45M | ||
General and Administrative Expenses | 8.86M | 12.81M | 24.84M | 36.09M | 38.08M | ||
Research And Development Expense From Footnotes | 2.5M | 5.29M | 16.26M | 24.05M | 15.24M | ||
Net Rental Expense, Total | 700K | 1.8M | 2.17M | 5.54M | 9.53M | ||
Imputed Operating Lease Interest Expense | - | - | 72.16K | 18.09K | 6.86K | ||
Imputed Operating Lease Depreciation | - | - | 2.1M | 5.52M | 9.53M | ||
Stock-Based Comp., COGS (Total) | - | - | - | - | 1.61M | ||
Stock-Based Comp., R&D Exp. (Total) | - | - | - | - | 2.6M | ||
Stock-Based Comp., S&M Exp. (Total) | - | - | - | - | 4.37M | ||
Stock-Based Comp., G&A Exp. (Total) | - | 5.98M | 13.28M | 18.93M | 9.98M | ||
Stock-Based Comp., Other (Total) | 1.3M | - | - | - | - | ||
Total Stock-Based Compensation | 1.3M | 5.98M | 13.28M | 18.93M | 18.56M |
- Stock Market
- Stocks
- DMTK Stock
- Financials DermTech
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















